VSX1错义突变的致病性及其与角膜病的关联
本研究在体外检测VSX1错义突变对转录抑制活性、蛋白稳定性及亚细胞定位的影响,并建立VSX1 p.P247R小鼠模型观察角膜与视网膜表型。结果显示该突变增强转录抑制活性,但小鼠无可见角膜缺陷,仅出现异常视网膜电图反应;作者认为VSX1单独不似角膜病的主要致病因素。
要点
- VSX1 p.P247R在体外增强转录抑制活性,但小鼠模型无可见角膜缺陷。
- 该小鼠模型出现视网膜电图异常,表现为ON反应较OFF反应更突出。
- 其他VSX1错义突变或增强抑制活性或不改变活性,VSX1单独不似主要致病因素。
核心结论
- VSX1序列变异可改变转录活性,但在小鼠遗传模型中至少一种改变未导致角膜异常。
- 不能排除VSX1作为角膜病风险因素的作用,但其单独不似起主要致病作用。
研究设计与样本
- 在转染人胚胎肾293T细胞中,用荧光素酶报告基因检测、western blotting和免疫标记分别检测Vsx1转录抑制活性、蛋白稳定性和亚细胞定位。
- 建立VSX1 p.P247R小鼠遗传模型进行体内致病性研究。
- 开发未固定完整眼球的wholemount共聚焦成像方法,检查角膜形态、曲率和厚度。
- 用免疫标记和视网膜电图检查视网膜表型。
主要发现
- 对应人类VSX1 p.P247R的突变在体外导致转录抑制活性增强。
- VSX1 p.P247R小鼠模型无任何可观察到的角膜缺陷。
- 该小鼠模型视网膜电图异常,表现为全视网膜ON反应较OFF反应更突出。
- 对其他VSX1错义突变的体外分析显示,它们或增强抑制活性或不改变活性。
临床怎么用
- 对携带VSX1错义变异的角膜病家系,不宜仅凭变异推断其单独致病。
- VSX1变异解读需结合功能实验与动物模型证据,并关注视网膜表型。
- VSX1可作为角膜病风险因素考虑,但需谨慎评估其临床意义。
局限性
- 研究采用小鼠遗传模型,结果外推至人类角膜病需谨慎。
- 摘要未报告样本量、统计阈值及置信区间等定量信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Despite numerous studies associating Visual System Homeobox 1 (VSX1), with posterior polymorphous corneal dystrophy and keratoconus, its role in these diseases is unclear. Here we examine the pathogenicity of VSX1 missense mutations in vitro and in a mouse genetic model. METHODS: Vsx1 transcriptional repressor activity, protein stability, and subcellular localization activity, was examined using luciferase reporter-based assays, western blotting and immunolabeling, respectively, in transfected human embryonic kidney 293T cells. A genetic model for VSX1 p.P247R was generated to investigate pathogenicity of the mutation, in vivo. A wholemount confocal imaging approach on unfixed intact eyes was developed to examine corneal morphology, curvature, and thickness. Immunolabeling and electroretinography was used to examine retinal phenotype. RESULTS: A mutation corresponding to human VSX1 p.P247R led to enhanced transcriptional repressor activity, in vitro. A mouse model for VSX1 p.P247R did not have any observable corneal defect, but did exhibit an abnormal electroretinogram response characterized by a more prominent ON as opposed to OFF panretinal responsiveness. In vitro analysis of additional VSX1 missense mutations showed that they either enhanced repressor activity or did not alter activity. CONCLUSIONS: Our results indicate that although VSX1 sequence variants can alter transcriptional activity, in the context of a mouse genetic model, at least one of these changes does not lead to corneal abnormalities. While we cannot exclude a role for VSX1 as a risk factor for corneal disease, on its own, it does not appear to play a major causative role.
引用
- Litke AM, Samuelson S, Delaney KR, et al. Investigating the Pathogenicity of VSX1 Missense Mutations and Their Association With Corneal Disease. Invest Ophthalmol Vis Sci. 2018. PMID: 30535423. doi:10.1167/iovs.18-25490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。